Good Lifestyle

For most of us, drugs are part of daily life - you could take a daily pill to treat seasonal allergies or count on prescription treatment to keep a more serious illness under control. So when a drug isSubject to recall, it is naturally a little disconcerting. The Food and Drug Administration of the United States (FDA) has just announced that a drug is being implemented, and if you use it now, you will want to contact your doctor for advice. Read the rest to discover what the agency warns patients.

Read this then:This daily daily drug can become more difficult to find, say manufacturers.

During the summer, several drugs were taken from the shelves, in particularmorphine tablets Made by Bryant Ranch Prepack Inc. According to the FDA June 29 reminder, the tablets were drawn due to aProblem with labels. Morphine sulfate 30 mg of prolonged release tablets was poorly labeled in the form of 60 mg tablets, and the tablets of sulfate morphine of 60 mg were poorly labeled at 30 mg.

Following the mixture, patients prescribed that the 30 mg dose could make the tablets of 60 mg in error and put themselves at risk of overdose and death. And the prescribed 60 mg tablets that take 30 mg tablets could be at risk of withdrawal, as well as untreated pain, warned the FDA. Patients with medication were invited to stop using it immediately and contact the manufacturer.

In July, patients with diabetes dealt with a significant recall whenA batch of glargine insulin (Insulin glargine-yfgn) injection, 100 units / ml (U-100)voluntarily recalled By Mylan Pharmaceuticals Inc. It was again due to a labeling problem, according to the announcement of the FDA, because some insulin pens lacked labels. Patients could undergo "serious complications" if the products were mixed with different types of insulin, and they were invited to call the SEDGWICK recall company.

But the most recent recall is not the result of labeling problems - it is in fact due to potential contamination.

On September 26, theFDA announced That eugia us llc (formerlyAuromedics Pharma LLC), a company based in East Windsor, New Jersey, has published a voluntary recall of a batch of AcyClovir Sodium 500 mg injection by 10 ml (50 mg / ml), 10 ml of single dose bottle. The drug is known by theZovirax brand name.AE0FCC31AE342FD3A1346EBB1F342FCB

The drug contains acyclovir, which is a treatment used for herpes viruses, said FDA. The injection is used to treat "the simplex herpes (HSV-1 and HSV-2)" initial and recurrent "in immunocompromised patients, as well as" the initial clinical episodes of herpes genitalalis in immuno-compliant patients ", "meaning those who have a normal immune response.

Simply skin herpes can cause lesions on the skin, while mucous herpesaffects the mucosa, which is the "soft fabric that lines the canals and organs of the body", according to the Cleveland Clinic.

RELATED:For more up-to-date information, register for our daily newsletter.

According to the FDA announcement, the recall affects the number of Lot AC22006, which has an expiration date in August 2023. The products were shipped to wholesalers across the country between June 8 and 13, packaged in Glass bottles and labeled with the National Drug Code (NDC) 55150-154-10.

The bottles are recalled following a "product complaint", which noted "the presence of dark, brown and black particles inside the bottle".

EUGIA US LLC has not received any report of adverse events related to the reminded lot. However, the products that contain these particles could lead to "inflammation, allergic reactions or complications of the circulatory system" which could become fatal, notes the FDA.

If you have a product recalled in your pharmacy cabinet - and especially if you have health problems related to the product - the FDA asks you to call your doctor. Consumers must also call Quadanex (which provides support services for Eugia) at 1-888-280-2046 between 7 a.m. and 4 p.m. Standard central time, Monday to Friday, or send an email to the company to[Protected by e-mail]

According to the reminder announcement, Eugia US LLC sends recall letters to those who received the product, organizing return and replacement. Wholesalers and health professionals are invited to immediately suspend the batch recalled and to contact Quadane.

Consumers can report quality problems and adverse reactions to FDA Medwatch unwanted events online program, or by Mail or ordinary fax .